Cargando…
Anti-microRNAs as Novel Therapeutic Agents in the Clinical Management of Alzheimer's Disease
Overview- One hundred and ten years since its first description Alzheimer's disease (AD) still retains its prominent status: (i) as the industrialized world's number one cause of age-related intellectual impairment and cognitive decline; (ii) as this country's most rapidly expanding s...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766517/ https://www.ncbi.nlm.nih.gov/pubmed/26941600 http://dx.doi.org/10.3389/fnins.2016.00059 |